During the fourth quarter ended December 2013 the healthcare firm reported a net profit of Rs 92.70 crore, up 107% compared with Rs 44.8 crore in the corresponding quarter last year.
Total income from operations during the quarter under review increased to Rs 488.30 crore up, 15% compared with Rs 422.80 crore in the fourth quarter ended December 2012.
Also Read
Further, the company's board at its meeting held on February 25, 2014, have proposed a final dividend of Rs 35 per equity share of face value Rs 10 each.
Sanofi India offers medicines for several therapeutic segments such as cardiology, thrombosis, oncology, central nervous system, diabetes, internal medicine and consumer healthcare.